The latest update is out from MIRA Pharmaceuticals, Inc. (MIRA).
MIRA Pharmaceuticals has revised its employment agreement with CFO Michelle Yanez, reducing her salary from $225,000 to $137,500 while allowing her to also serve other companies affiliated with Bay Shore Trust. Additionally, the company is gearing up for its first Annual Meeting of Shareholders on September 12, 2024, and has set a July 12 deadline for shareholder proposals and director nominations. This is a crucial time for investors to participate and engage with the company’s future direction.
See more insights into MIRA stock on TipRanks’ Stock Analysis page.
